NGC 1566 is a changing look AGN known to exhibit recurrent X-ray outbursts with each lasting for several years. The most recent X-ray outburst is observed on 2018, with a substantial increase of 2-10 keV flux by a factor of ∼24 than the historical minimum. We re-analyze the XMM-Newton and NuSTAR observations covering the pre-outburst, outburst and post-outburst epochs, and confirm the discovery of the broad feature in the ∼5-7 keV band during the period of outburst that could be interpreted as a relativistic Fe Kα emission line. Our analysis suggests that its flux has increased in tandem with the 2-10 keV continuum, making it the second changing look AGN in which the broad Fe Kα line responds to the X-ray continuum variability. This behavior strongly supports the idea that X-rays originates in a corona above the accretion disk, and disk reflection produces the relativistic Fe Kα line. In addition, we find the response of narrow Fe Kα emission line to the changes in the X-ray continuum on a time-scale as short as four months, allowing to put the location of line-emitting region at <0.1 pc, comparable to the size of optical BLR. By comparing to the changing look AGN NGC 2992, the Fe Kα variation rate (the ratio of Fe Kα variation to luminosity variation) in NGC 1566 appears greater, which could be possibly explained by larger amount of gas or Fe abundance responsible for producing the Fe Kα line for the latter. The strength of variable broad Fe Kα line as well as the soft X-ray excess emission appears to be correlated with the accretion rate, which could be explained as due to the state transition associated with the changing-look phenomenon.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.